Evidence map›Paper›PMID 34303699›Full record

ArticleThe American journal of pathology2021

Myeloid Cells Are Enriched in Tonsillar Crypts, Providing Insight into the Viral Tropism of Human Papillomavirus.

Austin K Mattox, Jessica Roelands, Talia M Saal, Yang Cheng, Darawan Rinchai, Wouter Hendrickx, Geoffrey D Young, Thomas J Diefenbach, Alan E Berger, William H Westra and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. HPV in oropharyngeal squamous papillomas: a missing link in head and neck viral pathogenesis.Virchows Archiv : an international journal of pathology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

Austin K MattoxDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jessica RoelandsCancer Program, Research Branch, Sidra Medicine, Doha, Qatar; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Talia M SaalDivision of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Yang ChengDivision of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Darawan RinchaiCancer Program, Research Branch, Sidra Medicine, Doha, Qatar.
Wouter HendrickxCancer Program, Research Branch, Sidra Medicine, Doha, Qatar.
Geoffrey D YoungMiami Cancer Institute and Department of Surgery, Florida International University, Miami, Florida.
Thomas J DiefenbachRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts.
Alan E BergerDivision of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
William H WestraDepartment of Pathology, Icahn School of Medicine at the Mount Sinai Hospital, New York, New York.
Justin A BishopDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
William C FaquinDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
Francesco M MarincolaRefuge Biotechnologies, Menlo Park, California.
Mikael J PittetCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Davide BedognettiCancer Program, Research Branch, Sidra Medicine, Doha, Qatar.
Sara I PaiDivision of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: sara.pai@mgh.harvard.edu.
Harvard University · USJohns Hopkins University · USFlorida International University · USLeiden University Medical Center · NLMassachusetts General Hospital · USMount Sinai Hospital · USRagon Institute of MGH, MIT and Harvard · USRefuge Biotechnologies (United States) · USThe University of Texas Southwestern Medical Center · US

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Strategies to Overcome Immune Resistance in Head and Neck CancersP01CA240239 · NCI · YALE UNIVERSITY · PI PAI, SARA ISABEL · 2019 to 2023
$8.4M
FAST-FNA immune cell profiling in HNSCCR01CA257623 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FAQUIN, WILLIAM CLAY, WEISSLEDER, MD, PHD, RALPH · 2021 to 2025
$3.3M
Immune Checkpoints and HPV-associated Head and Neck CancersR01DE025340 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI PAI, SARA ISABEL · 2015 to 2017
$1.3M
NCI NIH HHS P01 CA240239NCI NIH HHS R01 CA257623NIDCR NIH HHS R01 DE025340NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

Viruses are the second leading cause of cancer worldwide, and human papillomavirus (HPV)-associated head and neck cancers are increasing in incidence in the United States. HPV preferentially infects the crypts of the tonsils rather than the surface epithelium. The present study sought to characterize the unique microenvironment within the crypts to better understand the viral tropism of HPV to a lymphoid-rich organ. Laser-capture microdissection of distinct anatomic areas (crypts, surface epithelium, and germinal centers) of the tonsil, coupled with transcriptional analysis and multiparameter immunofluorescence staining demonstrated that the tonsillar crypts are enriched with myeloid populations that co-express multiple canonical and noncanonical immune checkpoints, including PD-L1, CTLA-4, HAVCR2 (TIM-3), ADORA2A, IDO1, BTLA, LGALS3, CDH1, CEACAM1, PVR, and C10orf54 (VISTA). The resident monocytes may foster a permissive microenvironment that facilitates HPV infection and persistence. Furthermore, the myeloid populations within HPV-associated tonsil cancers co-express the same immune checkpoints, providing insight into potential novel immunotherapeutic targets for HPV-associated head and neck cancers.

Indexed as

AlphapapillomavirusAntigens, CDB7 AntigensB7-H1 AntigenCell Adhesion MoleculesEpitheliumGerminal CenterHead and Neck NeoplasmsHumansImmune Checkpoint ProteinsLaser Capture MicrodissectionMonocytesMyeloid CellsPalatine TonsilReceptors, VirusTranscriptomeAntigens, CDB7 AntigensB7-H1 AntigenCD274 protein, humanCD66 antigensCell Adhesion MoleculesImmune Checkpoint Proteinspoliovirus receptorReceptors, VirusVSIR protein, human

Identifiers

PMID34303699
PMCPMC8491092
OpenAlexW3185458213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.